Table 2.
Clinical characteristics of study population by glucose tolerance status
| Variable | Euglycemic | IGT and/or IFG | Diabetes |
|---|---|---|---|
| N | 192 | 119 | 89 |
| Age | 47.4 ± 13.2 | 49.49 ± 14.09 | 57.93 ± 11.47 |
| Sex (M/F) | 99/93 | 52/67 | 31/58 |
| Height (cm) | 160.99 ± 9.28 | 158.28 ± 8.59 | 157.86 ± 9.32 |
| Weight (kg) | 62.66 ± 11.41 | 64.68 ± 12.04 | 63.97 ± 12.15 |
| BMI (kg/m2) | 24.21 ± 4.22 | 25.85 ± 4.67 | 25.68 ± 4.46 |
| Waist circumference (cm) | 82.73 ± 9.86 | 85.47 ± 9.57 | 86.59 ± 10.51 |
| Hip circumference (cm) | 98.55 ± 8.40 | 101.62 ± 10.11 | 101.04 ± 9.37 |
| WHR | 0.84 ± 0.07 | 0.84 ± 0.06 | 0.86 ± 0.07 |
| Fat mass (%) | 21.82 ± 8.44 | 24.86 ± 10.66 | 23.67 ± 7.55 |
| Fasting glucose (mmol/l) | 5.87 ± 2.36 | 5.72 ± 0.80 | 10.85 ± 4.25 |
| 2 hour glucose (mmol/l) | 7.93 ± 3.79 | 9.96 ± 2.86 | 13.24 ± 5.22 |
| Fasting insulin (pmol/l) | 12.03 ± 6.41 | 14.03 ± 7.17 | 12.95 ± 6.99 |
| HbA1c | 5.22 ± 1.38 | 5.07 ± 0.53 | 8.06 ± 1.93 |
| HDL cholesterol (mmol/l) | 1.19 ± 0.30 | 1.23 ± 0.31 | 1.18 ± 0.30 |
| LDL cholesterol (mmol/l) | 3.42 ± 0.94 | 3.59 ± 0.90 | 3.66 ± 0.98 |
| Total cholesterol (mmol/l) | 5.35 ± 1.03 | 5.60 ± 1.03 | 5.82 ± 1.19 |
| Triglycerides (mmol/l) | 1.59 ± 0.90 | 1.70 ± 0.87 | 2.03 ± 1.09 |
| Leptin (ng/ml) | 15.13 ± 12.32 | 21.40 ± 17.13 | 18.31 ± 13.43 |
| Diastolic BP (mmHg) | 75.95 ± 14.27 | 77.97 ± 15.30 | 82.48 ± 12.69 |
| Systolic BP (mmHg) | 128.06 ± 23.32 | 133.43 ± 22.25 | 147.11 ± 24.76 |
| Creatinine (mmol/l) | 8.95 ± 5.53 | 7.68 ± 5.27 | 6.99 ± 4.18 |
| Urate (umol/l) | 267.94 ± 80.70 | 286.27 ± 72.35 | 255.98 ± 92.11 |